Pharmacytimes: Condition Center: Mental Health http://www.pharmacytimes.com/condition-resources/mental-health/condition-rss Mental Health en-us Mon, 23 Oct 2017 09:43:19 UTC Mon, 23 Oct 2017 09:43:19 UTC 5 Psychiatry Studies Pharmacists Should Know About http://www.pharmacytimes.com/contributor/timothy-o-shea/2017/09/5-psychiatry-studies-pharmacists-should-know-about Over the years, a number of landmark clinical studies in the field of psychiatry have been published, shaping how we treat mental illness. Here are 5 that every pharmacist should know about. 3:47 AM, Wed September 20, 2017 Pharmacists Can Play Important Role in Depression Screening http://www.pharmacytimes.com/publications/issue/2017/August2017/pharmacists-can-play-important-role-in-depression-screening According to the US Preventive Services Task Force&#39;s (USPSTF) updated recommendations for depression screening in adults, major depressive disorder is the leading cause of disability among adults in high-income countries. 3:10 PM, Sun September 3, 2017 What is the National Council on Patient Information and Education? http://www.pharmacytimes.com/contributor/steve-leuck-pharmd/2017/08/what-is-the-national-council-on-patient-information-and-education Here is the 411 on this organization, which offers programs to help consumers better understand their medications. 11:36 PM, Wed August 23, 2017 Management of Psychosis in Parkinson's Disease: Clinical Tidbits http://www.pharmacytimes.com/contributor/chris-tanski-pharmd/2017/05/management-of-psychosis-in-parkinsons-disease-clinical-tidbits What are the best practice considerations for managing Parkinson's Psychosis? 11:26 PM, Tue May 9, 2017 Carving Out a Niche in the Treatment of Tardive Dyskinesia http://www.pharmacytimes.com/contributor/austin-hewlett-pharmd-mba-candidate/2017/05/carving-out-a-niche-in-the-treatment-of-tardive-dyskinesia The FDA recently approved Ingrezza (valbenazine) for the treatment of adults with tardive dyskinesia. 1:33 AM, Wed May 3, 2017 5 Interesting Medication Case Reports - Part 3 http://www.pharmacytimes.com/contributor/timothy-o-shea/2017/04/5-interesting-medication-case-reports---part-3 This article highlights 5 published case reports that document unusually high doses of medications that are not often seen in clinical practice. 9:54 PM, Wed April 26, 2017 Fighting the Stigma Around Mental Illness http://www.pharmacytimes.com/contributor/thora-brown-pharmd/2017/02/fighting-the-stigma-around-mental-illness What are you doing to stop the stigma surrounding mental illnesses? 10:46 PM, Mon February 20, 2017 The Key to Better Bipolar I Disorder Control? http://www.pharmacytimes.com/contributor/daniel-holland-pharmd/2017/02/the-key-to-better-bipolar-i-disorder-control What can you (or your pharmacist) do to improve Bipolar I Disorder outcomes? 8:20 PM, Sun February 12, 2017 Study Notes Missed Opportunity for HIV Detection http://www.pharmacytimes.com/resource-centers/hiv/study-notes-missed-opportunity-for-hiv-detection- A new study, published in <em>Psychiatric Services,</em> reveals a missed opportunity for early HIV detection and treatment.&nbsp; 9:44 AM, Tue January 24, 2017 Ajanta Launches Generic Abilify in US Market http://www.pharmacytimes.com/product-news/ajanta-launches-generic-abilify-in-us-market Ajanta has launched&nbsp;aripiprazole tablets in 2.5-mg, 5-mg, 10-mg, 15-mg, 20-mg, and 30-mg doses in the United States. 7:00 AM, Tue November 29, 2016 Study Shows More Than 50% of Americans Have at Least 1 Chronic Health Condition, Mental Disorder, or Substance Use Issue http://www.pharmacytimes.com/news/study-shows-more-than-50-of-americans-have-at-least-1-chronic-health-condition-mental-disorder-or-substance-use-issue <p>The election has brought discussion about the complexity of the US health care system to the forefront. A new study from <em>Psychology, Health &amp; Medicine</em> reveals just how intricate the medical needs of Americans really are.</p> 11:04 AM, Tue November 8, 2016 FDA Approves sNDA for Label Changes to ADASUVE http://www.pharmacytimes.com/product-news/fda-approves-snda-for-label-changes-to-adasuve The FDA has approved the supplemental New Drug Application for label changes to ADASUVE (loxapine) inhalation powder. 7:00 AM, Mon October 24, 2016 Vraylar http://www.pharmacytimes.com/publications/issue/2016/May2016/Vraylar The FDA has approved Vraylar, an atypical antipsychotic, for the treatment of schizophrenia and the acute treatment of mixed or manic episodes associated with bipolar I disorder. 5:25 AM, Fri May 13, 2016 Ideal Adherence Interventions for Bipolar Patients http://www.pharmacytimes.com/resource-centers/bipolar-disorder/ideal-adherence-interventions-for-bipolar-patients Patients diagnosed with bipolar disorder are at very high risk for medication nonadherence. 12:06 AM, Fri March 18, 2016 Common Antipsychotic Linked to Compulsive Gambling http://www.pharmacytimes.com/contributor/steve-leuck-pharmd/2016/01/common-antipsychotic-linked-to-compulsive-gambling There is a potential correlation between aripiprazole use and increased risk for compulsive gambling and hypersexuality. 1:16 AM, Tue January 19, 2016 Adding Anticonvulsant to Antipsychotic May Benefit Bipolar Patients http://www.pharmacytimes.com/resource-centers/bipolar-disorder/adding-anticonvulsant-to-antipsychotic-may-benefit-bipolar-patients Combining lamotrigine with quetiapine may improve depressive symptoms and clinical remission rates in patients with bipolar disorder. 9:46 PM, Wed January 13, 2016 10 Surprising Off-Label Uses for Prescription Medications http://www.pharmacytimes.com/contributor/timothy-o-shea/2016/01/10-surprising-off-label-uses-for-prescription-medications How many of these off-label uses have you seen before? 4:01 AM, Tue January 5, 2016 Vraylar Approved for Schizophrenia, Bipolar Disorder http://www.pharmacytimes.com/product-news/vraylar-approved-by-fda-to-treat-schizophrenia-and-bipolar The FDA has approved cariprazine (Vraylar) to treat schizophrenia and manic or mixed episodes associated with bipolar disorder. 8:46 AM, Fri September 18, 2015 Bipolar Depression: Which Drug Works Best? http://www.pharmacytimes.com/resource-centers/bipolar-disorder/bipolar-depression-which-drug-works-best Clinicians would like to have better information about treatment options for bipolar depression, but clinical trials of any length are scarce. 10:00 PM, Mon September 14, 2015 Atypical Antipsychotic Lowers Bipolar Disorder Treatment Costs http://www.pharmacytimes.com/resource-centers/bipolar-disorder/atypical-antipsychotic-lowers-bipolar-disorder-treatment-costs In the recent past, bipolar disorder has been classified as the most costly mental illness. 10:52 PM, Mon August 31, 2015